Influence of Propylthiouracil and Methimazole Pre-treatment on the Outcome of Iodine-131 Therapy in Hyperthyroid Patients with Graves' Disease

被引：8
|
作者：
Shi, G-M [1 ]
Xu, Q. [2 ]
Zhu, C-Y [2 ]
Yang, Y-L [2 ]
机构：
[1] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Chemotherapy, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Nucl Med, Hangzhou 310003, Zhejiang, Peoples R China
来源：
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 2009年 / 37卷 / 02期
关键词：
GRAVES' DISEASE; HYPERTHYROIDISM; PROPYLTHIOURACIL; METHIMAZOLE; (131)I THERAPY; RADIOACTIVE IODINE THERAPY; RANDOMIZED CLINICAL-TRIAL; RADIOIODINE THERAPY; ANTITHYROID DRUGS; CURE RATES; EFFICACY;
D O I：
10.1177/147323000903700235
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
There is ongoing controversy about potential differences in the influence of the anti-thyroid drugs propylthiouracil (PTU) and methimazole (MMI) on radioiodine treatment of Graves' hyperthyroidism. This retrospective study investigated the influence of PTU and MMI pre-treatment, individually or sequentially, on the outcome of iodine-131 ((131)I) therapy in 199 patients with Graves' disease who had been treated with (131)I for the first time and followed up at 3 and 6 months after treatment. Pre-treatment with PTU, or sequential PTU and MMI pretreatment, increased the failure rate of (131)I therapy and reduced the rate of hypothyroidism. MMI pre-treatment alone had no significant influence on the results of (131)I therapy. Logistic regression analyses indicated that PTU pre-treatment and having a thyroid gland of > 60 g were both significantly related to (131)I therapy failure.
引用
收藏
页码：576 / 582
页数：7
相关论文
共 38 条
  • [21] Predictive factors for the outcomes of Graves' disease patients with radioactive iodine (131I) treatment
    Xing, Yu-Zhuo
    Zhang, Kun
    Jin, Gang
    BIOSCIENCE REPORTS, 2020, 40
  • [22] Could effective iodine-131 half-life be extended by lithium carbonate in Graves' disease patients: Results from a retrospective analysis
    Gao, Xuemei
    Wu, Binbin
    Zhou, Qian
    Liu, Yan
    Wang, Ruihua
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (06): : 1711 - 1716
  • [23] Comparison of Fixed 10 mCi and 15 mCi Iodine-131 Doses for the Treatment of Graves' Disease: 11 Year Study
    Dede, Fuat
    Ones, Tunc
    Candemir, Sinem
    Novruzov, Fuad
    Gungor, Serkan
    Aras, Mustafa
    Ozguven, Salih
    Inanir, Sabahat
    Erdil, Tanju Yusuf
    Turoglu, Halil Turgut
    MARMARA MEDICAL JOURNAL, 2011, 24 (01): : 26 - 30
  • [24] Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome
    Reinhardt, MJ
    Brink, I
    Joe, AY
    von Mallek, D
    Ezziddin, S
    Palmedo, H
    Krause, TM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (09) : 1118 - 1124
  • [25] Influence of Short-Term Dietary and Therapeutic Iodine Restriction on the Therapeutic Effects of Radioactive Iodine Therapy in Patients with Graves' Disease
    Nishio, Rie
    Uchida, Toyoyoshi
    Suzuki, Luka
    Onose, Hiroyuki
    Goto, Hiromasa
    Yamada, Emiko
    Satoh, Hiroaki
    Watada, Hirotaka
    THYROID, 2021, 31 (03) : 439 - 445
  • [26] Effect of methimazole treatment for 2 years on circulating IL-4, IgE, TBII, and TSAb in patients with hyperthyroid Graves' disease
    Yamada, Takashi
    Komiya, Ichiro
    Miyahara, Yasuhiro
    Komatsu, Mitsuhiro
    Shima, Ikuno
    Inazawa, Takeshi
    Aizawa, Toru
    ENDOCRINE JOURNAL, 2006, 53 (06) : 783 - 788
  • [27] The distribution of the major peripheral blood T, B and NK cell subsets does not predict the clinical outcome of Graves' disease patients after methimazole therapy
    Corrales, JJ
    López, A
    Ciudad, J
    Orfao, A
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2000, 14 (03) : 193 - 199
  • [28] Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU)
    Kubota, Sumihisa
    INTERNAL MEDICINE, 2016, 55 (22) : 3235 - 3237
  • [29] Duration of antithyroid drug treatment may predict weight gain after radioactive iodine therapy in patients with Graves? disease
    Yotsapon, Thewjitcharoen
    Waralee, Chatchomchuan
    Hussamon, Prasatkaew
    Panita, Srichomchey
    Siriwan, Butadej
    Soontaree, Nakasatien
    Ekgaluck, Wanothayaroj
    Rajata, Rajatanavin
    Thep, Himathongkam
    HELIYON, 2022, 8 (05)
  • [30] Initial activity-related long-term outcome of iodine-131 treatment for thyroidectomy patients with differentiated thyroid carcinoma
    Hung, Mao-Chin
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2020, 23 (03): : 246 - 250
1234